PMID- 24595220 OWN - NLM STAT- MEDLINE DCOM- 20140611 LR - 20211021 IS - 1530-0293 (Electronic) IS - 0090-3493 (Print) IS - 0090-3493 (Linking) VI - 42 IP - 5 DP - 2014 May TI - Transient receptor potential melastatin 8 channel inhibition potentiates the hypothermic response to transient receptor potential vanilloid 1 activation in the conscious mouse. PG - e355-63 LID - 10.1097/CCM.0000000000000229 [doi] AB - OBJECTIVES: Mild decrease in core temperature (therapeutic hypothermia) provides lasting neuroprotection following cardiac arrest or cerebral ischemia. However, current methods for producing therapeutic hypothermia trigger a cold-defense response that must be countered by sedatives, muscle paralytics, and mechanical ventilation. We aimed to determine methods for producing hypothermia in the conscious mouse by targeting two transient receptor potential channels involved in thermoregulation, two transient receptor potential (TRP) channels involved in thermoregulation, TRP vanilloid 1 (TRPV1) and TRP melastatin 8 (TRPM8). DESIGN: Controlled prospective animal study. SETTING: Research laboratory at academic medical center. SUBJECTS: Conscious unrestrained young and aged male mice. INTERVENTIONS: Mice were treated with the TRPV1 agonist dihydrocapsaicin, a TRPM8 inhibitor ("compound 5"), or their combination and the effects on core temperature (Tcore) were measured by implanted thermocouples and wireless transponders. MEASUREMENTS AND MAIN RESULTS: TRPV1 agonist dihydrocapsaicin produced a dose-dependent (2-4 mg/kg s.c.) drop in Tcore. A loading dose followed by continuous infusion of dihydrocapsaicin produced a rapid and prolonged (> 6 hr) drop of Tcore within the therapeutic range (32-34 degrees C). The hypothermic effect of dihydrocapsaicin was augmented in aged mice and was not desensitized with repeated administration. TRPM8 inhibitor "compound 5" (20 mg/kg s.c.) augmented the drop in core temperature during cold exposure (8 degrees C). When "compound 5" (30 mg/kg) was combined with dihydrocapsaicin (1.25-2.5 mg/kg), the drop in Tcore was amplified and prolonged. CONCLUSIONS: Activating warm receptors (TRPV1) produced rapid and lasting hypothermia in young and old mice. Furthermore, hypothermia induced by TRPV1 agonists was potentiated and prolonged by simultaneous inhibition of TRPM8. FAU - Feketa, Viktor V AU - Feketa VV AD - 1Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX. 2Department of Anesthesiology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China. 3Department of Anesthesiology, Baylor College of Medicine, Houston, TX. 4Drug Discovery, Janssen Research & Development, LLC, Spring House, PA. FAU - Zhang, Yi AU - Zhang Y FAU - Cao, Zhijuan AU - Cao Z FAU - Balasubramanian, Adithya AU - Balasubramanian A FAU - Flores, Christopher M AU - Flores CM FAU - Player, Mark R AU - Player MR FAU - Marrelli, Sean P AU - Marrelli SP LA - eng GR - R01 HL088435/HL/NHLBI NIH HHS/United States GR - R21 NS077413/NS/NINDS NIH HHS/United States GR - HL088435/HL/NHLBI NIH HHS/United States GR - NS077413/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Crit Care Med JT - Critical care medicine JID - 0355501 RN - 0 (3-(7-trifluoromethyl-5-(2-trifluoromethylphenyl)-1H-benzimidazol-2-yl)-1-oxa-2-azaspiro(4.5)dec-2-ene) RN - 0 (Benzimidazoles) RN - 0 (Isoxazoles) RN - 0 (TRPM Cation Channels) RN - 0 (TRPM8 protein, mouse) RN - 0 (TRPV Cation Channels) RN - 0 (TRPV1 protein, mouse) RN - S07O44R1ZM (Capsaicin) RN - W9BV32M08A (dihydrocapsaicin) SB - IM MH - Age Factors MH - Analysis of Variance MH - Animals MH - Benzimidazoles/*pharmacology MH - Body Temperature Regulation/*physiology MH - Capsaicin/*analogs & derivatives/pharmacology MH - Disease Models, Animal MH - Hypothermia, Induced/*methods MH - Isoxazoles/*pharmacology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - TRPM Cation Channels/administration & dosage/*antagonists & inhibitors MH - TRPV Cation Channels/administration & dosage/*agonists PMC - PMC4137592 MID - NIHMS606031 COIS- Copyright Form Disclosures: The remaining authors have disclosed that they do not have any potential conflicts of interest. EDAT- 2014/03/07 06:00 MHDA- 2014/06/12 06:00 PMCR- 2015/05/01 CRDT- 2014/03/06 06:00 PHST- 2014/03/06 06:00 [entrez] PHST- 2014/03/07 06:00 [pubmed] PHST- 2014/06/12 06:00 [medline] PHST- 2015/05/01 00:00 [pmc-release] AID - 10.1097/CCM.0000000000000229 [doi] PST - ppublish SO - Crit Care Med. 2014 May;42(5):e355-63. doi: 10.1097/CCM.0000000000000229.